The company itself is the constraint: demand outrunning its own ability to take it on, and management is spending to rai
The model's full reasoning — Q2 2017 call → NOWe need to determine if management conveys that the company's own capability is the binding limit on how big it can be right now, and that management is actively spending/building/hiring/organizing NOW to raise that limit, treating the race to expand its own capability as the central task. Let's analyze the transcript. The call covers Q2 2017 results, strategy updates, etc. Key themes: MS franchise growth, SPINRAZA launch, biosimilars, pipeline, business development, capital allocation, leaner operating model. Does management say that the company's own capability (production, people, facilities, systems, etc.) is the ceiling? Look for statements about demand outpacing capacity, or that they could do more business but are limited by internal factors. For SPINRAZA: They talk about infrastructure, sites, coverage. They mention "we are working closely with physicians to understand best practices to help these patients including alternate delivery options." They mention challenges with Type 2 patients due to spinal surgery, but that's about patient population, not company capability. They talk about expanding access, but not that they are limited by their own capacity. They mention "we are now building on this momentum outside the U.S." and "we are preparing our launch efforts" - that's about expansion, but not necessarily that demand is pressing against capacity. For MS: They talk about value-based contracting, but not about capacity limits. For pipeline: They talk about business development, but that's about acquiring assets, not about capacity. For manufacturing: Paul McKenzie talks about next-generation manufacturing platform, improving cycle times, reliability, etc. But is that framed as a response to demand pressing against capacity? He says "we really believe that if we can take – stand back, we have a great track record of developing and delivering high-quality products to the market. But when we look at our fundamental processes there's always opportunity to improve." That sounds like continuous improvement, not a race to expand to meet demand. They mention "we are actively reallocating resources to high-priority R&D BD and commercial growth opportunities." That's about reallocation, not expansion. They talk about "leaner and simpler operating model" to free up $400 million to reinvest.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| BRBR | BellRing Brands, Inc. | Q4 2023 | 2023-11-21 | B+ |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| TSSI | TSS, Inc. | Q4 2022 | 2023-04-03 | D |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| CHE | Chemed Corporation | Q3 2022 | 2022-11-01 | B+ |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| SYM | Symbotic Inc. | Q3 2022 | 2022-08-01 | B+ |
| JBHT | J.B. Hunt Transport Services, Inc. | Q2 2022 | 2022-07-19 | C+ |
| OGI | OrganiGram Holdings Inc. | Q3 2022 | 2022-07-14 | B+ |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GTES | Gates Industrial Corporation plc | Q4 2021 | 2022-02-07 | C+ |
| FORM | FormFactor, Inc. | Q4 2021 | 2022-02-02 | B |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| HNRG | Hallador Energy Company | Q3 2021 | 2021-11-09 | C+ |
| FSS | Federal Signal Corporation | Q1 2018 | 2018-05-12 | A |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| ZBH | Zimmer Biomet Holdings, Inc. | Q2 2017 | 2017-07-30 | F |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
ZBH · Q2 2017 → YESThe question is whether management conveys that the company's own ability to serve, supply, or take on business is the binding limit, and they're actively spending/building/hiring now to raise that li...YES The transcript shows management framing the Warsaw North Campus production delays and resulting back orders as the direct constraint on meeting existing customer demand and recapturing lost business, with steady market demand present but supply gating growth. They describe actively investing now in manufacturing remediation, quality enhancements, safety stock building, and sales force incentives and hires to restore full supply and return to offense, treating these as the central priority to expand capability and capture opportunities. This matches the criteria of internal capability as the binding limit and immediate action to raise it. The remediation is presented as urgent and ongoing rather than routine catch-up. The answer is YES.
FORM · Q4 2021 → YESThe question is whether management conveys that their own ability to serve/supply is the binding limit, and they're actively expanding now. YES The transcript shows management explicitly framing the company's internal limits—labor shortages in U.S. factories and extended lead times from sub-component delays—as the immediate ceiling on revenue growth, while simultaneously describing active, ongoing capital investments, facility expansions (Livermore), tool and labor additions, and supplier qualification efforts as the central priority to raise that ceiling and meet surging customer demand. This dual situation is presented as a present-tense reality driving the $850 million target path. The supply-chain component is acknowledged but subordinated to the claim that demand is outrunning current capability, and the build-out is treated as the key task ahead rather than routine maintenance.
FLUX · Q2 2022 → YESThe question is: Does management convey that the company's own ability to serve, supply, or take on business has become the binding limit on how big it can be right now — that real demand is pressing ...YES The transcript shows management explicitly framing the company's production capacity as the current binding limit: "We can’t build packs fast enough to keep up with the demand" and noting that supply-chain constraints (especially electronic components) are preventing them from serving the robust order flow and record backlog.